Andrea M. Denicoff, R.N., M.S.

Andrea Denicoff is a Health Scientist Administrator in the Clinical Investigations Branch with the Cancer Therapy Evaluation Program (CTEP) in the Division of Cancer Treatment & Diagnosis (DCTD) at the National Cancer Institute (NCI). In her role as the Head of Clinical Trials Operations for the NCI’s National Clinical Trials Network (NCTN), she works with the NCTN Lead Academic Participating Sites (LAPS) grantees on enhancing their accrual efforts within the NCTN.  She directs and manages projects to enhance access to clinical trials for both sites and patients, including broadening eligibility criteria in NCTN studies and streamlining clinical trial data requirements. She directs components of the Cancer Trials Support Unit (CTSU) that work on increasing education and awareness of NCI trials and conducting national coverage analyses reviews. She provides scientific review, leadership and coordination for patient reported outcomes (PROs) and health-related quality of life (HRQoL) research in cancer treatment studies. In addition, she is a Contracting Officer Representative for the NCI Clinical Trials Information and Management Support contract, serves as the CTEP representative to the Patient Advocate Steering Committee, and provides oversight and direction to the NCI’s Informed Consent Document Template.

Selected Publications 

• Implementing Modernized Eligibility Criteria in US National Cancer Institute Clinical Trials.
• The National Cancer Institute-American Society of Clinical Oncology Cancer Trial Accrual Symposium: summary and recommendations.
• Reporting of health-related quality of life endpoints in National Cancer Institute-supported cancer treatment trials.
• National Cancer Institute: Restructuring to Support the Clinical Trials of the Future.
• Racial/ethnic differences in clinical trial enrollment, refusal rates, ineligibility, and reasons for decline among patients at sites in the National Cancer Institute's Community Cancer Centers Program.